Physician profile
Marc J Devito
NPI 1295920262
$1,329.78
in general payments reported to CMS, 2019-2025
17 companies · $651 in 2025
The $651 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $55.91 · 2021: $113 · 2022: $237 · 2023: $27.35 · 2024: $93.91 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $411 · Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $411.00 |
| Food and Beverage | $361.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor (International) Ltd. | $411.00 | 2025 | |
| Ibsa Pharma INC. | $298.23 | 2019-2025 | Tirosint, Tirosint, Licart |
| Amarin Pharma, INC. | $124.72 | 2019 | |
| Sk Life Science, INC. | $124.16 | 2022 | |
| Antares Pharma, INC. | $69.79 | 2022-2025 | Xyosted |
| Convatec INC. | $44.03 | 2024 | |
| Dendreon Pharmaceuticals LLC | $35.73 | 2022 | |
| Urogen Pharma, INC. | $29.90 | 2022-2025 | |
| Novo Nordisk INC | $28.82 | 2024-2025 | Rybelsus, Ozempic |
| Progenics Pharmaceuticals, INC. | $24.86 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.44 | 2025 | |
| Tempus Ai, INC | $24.22 | 2025 | Xt Cdx |
| Bioprotect Medical, INC. | $20.58 | 2025 | Bioprotect Balloon Implant System |
| Coloplast Corp | $19.53 | 2025 | |
| Janssen Biotech, INC. | $17.97 | 2025 | Erleada |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $17.95 | 2024 | NP Thyroid 60 |
| Teleflex LLC | $13.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Devito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.